Genomics pioneer Craig Venter’s DNA used in Canadian study
Craig Venter's DNA has been used in a Canadian study aimed at sequencing a complete human genome. The research, conducted at SickKids hospital, seeks to minimize gaps in genetic sequencing that can obscure disease-related variations. Venter, who passed away in April 2023, was actively involved in the study's preparation prior to his death.
- ▪Craig Venter donated blood for the study during a visit to Toronto's SickKids hospital.
- ▪The research aims to create a near-complete human genome sequence at a reasonable cost.
- ▪Venter's DNA was chosen because it had previously been sequenced, providing a valuable reference for the study.
Opening excerpt (first ~120 words) tap to expand
Open this photo in gallery:Scientist and author Craig Venter signs copies of his book at the Arts and Letters club in Toronto, in October, 2023.Melissa Tait/The Globe and MailShareSave for laterPlease log in to bookmark this story.Log InCreate Free AccountTwo and half years ago, Craig Venter, the scientist-entrepreneur who is best known for accelerating the race to sequence the human genome, donated blood during a visit to Toronto’s SickKids hospital in hopes of sparking another leap forward.Now, Dr. Venter, who died on April 29, has got his wish. He is a posthumous co-author on what is likely to be his final contribution to science: a technique for sequencing the most complete version of a human genome possible for a reasonable cost.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Globe and Mail.
Discussion
0 commentsMore from The Globe and Mail
